TITLE

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

AUTHOR(S)
Sattler, Fred R.; Cowan, Robert; Nielsen, Donald M.; Ruskin, Joel; Sattler, F R; Cowan, R; Nielsen, D M; Ruskin, J
PUB. DATE
August 1988
SOURCE
Annals of Internal Medicine;8/15/88, Vol. 109 Issue 4, p280
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Study Objective: To ascertain the efficacy and toxicity of trimethoprim-sulfamethoxazole or pentamidine when either is given alone during the entire treatment period for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome (AIDS).Design: Prospective, randomized, noncrossover comparison of trimethoprim-sulfamethoxazole with pentamidine. Trimethoprim-sulfamethoxazole dosage was adjusted to maintain serum trimethoprim at 5 to 8 micrograms/mL. Pentamidine dosage was reduced by 30% to 50% for an absolute rise in serum creatinine of more than 88 mumol/L (1 mg/dL).Setting: Tertiary care hospital and AIDS clinic.Patients: Thirty-six patients were treated with trimethoprim-sulfamethoxazole and 34 with pentamidine. Pretreatment clinical features and laboratory test results were similar in the two groups.Measurements and Main Results: Thirty-six recipients of trimethoprim-sulfamethoxazole and 33 recipients of pentamidine completed therapy without crossover. Trimethoprim-sulfamethoxazole caused a rash (44%) and anemia (39%) more frequently (P less than or equal to 0.03, whereas pentamidine caused nephrotoxicity (64%), hypotension (27%), or hypoglycemia (21%) more frequently (P less than or equal to 0.01). The (A - a)DO2 improved by greater than 1.3 kPa (10 mmHg) 8 days earlier for trimethoprim-sulfamethoxazole recipients (95% CI for the difference in response, -1 to 17; P = 0.04). Thirty-one (86%) patients treated with trimethoprim-sulfamethoxazole and 20 (61%) with pentamidine survived and were without respiratory support at completion of treatment (95% CI for the difference in response, 5% to 45%; P = 0.03).Conclusions: For most patients with AIDS and P. carinii pneumonia, successful treatment with a single agent is possible. Toxicity associated with the two standard treatments is rarely life-threatening and may be diminished if the trimethoprim-sulfamethoxazole dosage is modified by pharmacokinetic monitoring and the pentamidine dosage is reduced for nephrotoxicity. Oxygenation improved more quickly and survival was better with trimethoprim-sulfamethoxazole.
ACCESSION #
6953377

 

Related Articles

  • Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Wharton, J. Marcus; Coleman, Diana Lewis; Wofsy, Constance B.; Luce, John M.; Blumenfeld, Walter; Hadley, W. Keith; Ingram-Drake, Leslie; Volberding, Paul A.; Hopewell, Philip C.; Wharton, J M; Coleman, D L; Wofsy, C B; Luce, J M; Blumenfeld, W; Hadley, W K; Ingram-Drake, L; Volberding, P A; Hopewell, P C // Annals of Internal Medicine;Jul86, Vol. 105 Issue 1, p37 

    Forty patients with the acquired immunodeficiency syndrome (AIDS) and their first episodes of Pneumocystis carinii pneumonia were assigned at random to receive either trimethoprim-sulfamethoxazole or pentamidine isethionate. The two groups did not differ significantly in the severity of...

  • Cotrimoxazole.  // Reactions Weekly;1/21/2017, Vol. 1635 Issue 1, p95 

    An abstract of the article "Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: A case report and literature review" by H. Li and others is presented.

  • Prophylaxis Recommendations for Pneumocystis. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;3/25/2002, Vol. 15 Issue 3, p110 

    Reports the indication of primary prophylaxis of Pneumocystis for patients with history of Pneumocystis carinii pneumonia. Efficacy of trimethoprim-sulfamethoxazole (TMP-SMX); Considerations in discontinuing primary and secondary prophylaxis; Dosage for TMP-SMX.

  • Clindamycin/tacrolimus interaction.  // Reactions Weekly;10/2/2010, Issue 1321, p14 

    The article describes the case of a woman who experienced decreased serum tacrolimus concentrations after starting clindamycin to treat Pneumocystis carinii (P. jirovecii) pneumonia.

  • Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis carinii Pneumonia. Winston, Drew J.; Lau, William K.; Gale, Robert Peter; Young, Lowell S. // Annals of Internal Medicine;Jun80, Vol. 92 Issue 6, p762 

    Presents a study which evaluated trimethoprim-sulfamethoxazole for the treatment of patients with Pneumocystis carinii pneumonia. Background on the clinical data of patients involved in the study; Comparison of clinical responses and side effects associated with trimethoprim-sulfamethoxazole...

  • Acute Megaloblastic Anemia Induced by High-Dose Trimethoprim-Sulfamethoxazole. Kobrinsky, Nathan; Ramsay, Norma K.C. // Annals of Internal Medicine;Jun81, Vol. 94 Issue 6, p780 

    Presents a case study of the development of acute megaloblastic anemia in a 22-year-old woman after treatment with high-dose trimethoprim-sulfamethoxazole for pneumocystis pneumonia. Background on the therapeutic applications of trimethoprim-sulfamethoxazole; Medical history of the patient;...

  • Questions Regarding the Effectiveness of Trimethoprim-Sulfamethoxazole (Cotrimoxazole) Prophylaxis in African Children. Gill, Christopher J.; Hamer, Davidson; Thea, Donald M. // Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, p863 

    Presents a letter to the editor in the September 15, 2003 issue of 'Clinical Infectious Diseases,' regarding the article 'Ineffectiveness of trimethoprime-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii...

  • Reply. Madhi, Shabir A.; Klugman, Keith P. // Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, p864 

    Responds to comments on the authors' article 'Ineffectiveness of trimethoprime-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia,' published in a 2003 issue of 'Clinical Infectious Diseases.'

  • Cotrimoxazole.  // Reactions Weekly;11/21/2009, Issue 1279, p16 

    The article describes the case of a 44-year-old man with Pneumocystis carinii pneumonia (PCP) who died despite treatment with cotrimoxazole. The patient, who had undergone renal transplant, received antilymphocyte globulin before he was given ciclosporin, prednisolone and mycophenolate mofetil...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics